Copyright
©2010 Baishideng.
World J Gastrointest Endosc. Jan 16, 2010; 2(1): 36-40
Published online Jan 16, 2010. doi: 10.4253/wjge.v2.i1.36
Published online Jan 16, 2010. doi: 10.4253/wjge.v2.i1.36
Table 3 Ulcer size reduction rate
| Lafutidine | Rabeprazole | P | |
| Ulcer size (Day 0) | 33.3 ± 9.2 | 34.7 ± 11.3 | 0.635 |
| Ulcer size (Day 28) | 10.5 ± 4.8 | 11.8 ± 6.7 | 0.421 |
| Reduction rate | 32.30% | 33.50% | 0.974 |
-
Citation: Ohya TR, Endo H, Kawagoe K, Yanagawa T, Hanawa K, Ohata K, Asayama M, Hisatomi K, Teratani T, Gunji T, Sato H, Matsuhashi N. A prospective randomized trial of lafutidine
vs rabeprazole on post-ESD gastric ulcers. World J Gastrointest Endosc 2010; 2(1): 36-40 - URL: https://www.wjgnet.com/1948-5190/full/v2/i1/36.htm
- DOI: https://dx.doi.org/10.4253/wjge.v2.i1.36